The primary tumour resection with extended D3 lymph node dissection, metastases of synchronous metastatic colorectal cancer

Close metadata

Recommended articles:

Optimal prevention of VTE in cancer surgery patients with impaired renal function. Pirogov Russian Journal of Surgery. 2024;(1):119-126

Socio-economic efficiency of the early cancer detection during the medical checkup. Russian Journal of Preventive Medicine. 2024;(1):36-44

Diagnosis of septic complications of postpartum endometritis and treatment of laboring women. Russian Bulletin of Obstetrician-Gynecologist. 2024;(1):69-75

Endobronchial hamartoma. P.A. Herzen Journal of Oncology. 2024;(1):59-62

Convexity hyperostotic meningioma en plaque: a systematic review. Burdenko's Journal of Neurosurgery. 2024;(1):103-108

Assessment of the association of the CYP1A1 gene RS1048943 polymorphism in the colorectal cancer: a meta-analysis. Russian Journal of Preventive Medicine. 2024;(2):37-43

Minimally invasive surgical treatment of extramedullary tumors at the level of craniovertebral junction: experience of the Burdenko Neurosurgical Center. Burdenko's Journal of Neurosurgery. 2024;(2):39-46

Correction of anemia and mitochondrial dysfunction by iron citrate «Sintezit» during neoadjuvant chemotherapy for colorectal cancer and lymphoproliferative disorders. Russian Journal of Evidence-Based Gastroenterology. 2024;(1):21-31

Colorectal cancer: incidence, risk factors, and screening. Russian Journal of Preventive Medicine. 2024;(3):93-97

Patient-centered approach to assessing tolerability of antitumor treatment for oral cavity and oropharyngeal cancer. P.A. Herzen Journal of Oncology. 2024;(2):21-26

The progress in colorectal cancer treatment of IV stage that was shown in last decades was mainly due to modern chemotherapy schemes and aggressive surgical approach towards distant metastatic lesions. Meanwhile less attention is paid to primary tumour treatment - the questions of necessity and volume of its resection are still open. The AIM of this study was to evaluate safety and oncologic effectiveness of primary tumour resection with D3 lymph node dissection in synchronous metastatic colorectal cancer. Patients with colorectal cancer and synchronous metastatic lesion of distant organs who underwent surgical resection of primary tumour were chosen from prospectively collected department database. The analysis of short-term and long-term results of resections with and without extended D3 lymph node dissection and prognostic factors affecting overall survival was carried out. From 2006 to 2011 total of 190 patients underwent primary tumour resection, 157 (82.6%) among them - with extended D3 lymph node dissection. Twenty one patient (11%) developed postoperative complications that required reintervention, 30-days mortality rate was 2.6%. Three-year cumulative overall survival was 37%, median survival - 22 months (25 months with extended lymph node dissection and 4 months without, p<0.001). Univariate analysis revealed following statistically significant prognostic factors improving overall survival: metastatic lesions in one distant organ, solitary haematogenous nodes, extended D3 lymph node dissection, postoperative chemotherapy, resection of metastatic lesions. Removal of primary tumour with extended lymph node dissection in metastatic colorectal cancer doesn't increase the number of postoperative complications and mortality. Performing D3 lymph node dissection favours increase of median survival and is a significant prognostic factor influencing outcomes.

Keywords:

colorectal cancer

surgical treatment

extended lymph node dissection in the treatment of synchronous metastatic colorectal cancer

Authors:

Tsar'kov P.V.

Chair of Cardiovascular Surgery and Interventional Cardiology, I.M. Sechenov First Moscow State Medical University (head — MD R.N. Komarov), acad. B.V. Petrovsky Russian Research Center for Surgery (director — acad. of RAS Yu.V. Belov), Moscow, Russia

Kravchenko A.Iu.

Otdelenie koloproktologii s khirurgieĭ tazovogo dna

Tulina I.A.

Otdelenie koloproktologii s khirurgieĭ tazovogo dna

Mirakian S.S.

Otdelenie koloproktologii s khirurgieĭ tazovogo dna FGBU Rossiĭskiĭ nauchnyĭ tsentr khirurgii im. akad. B.V. Petrovskogo RAMN

List of references:

Vorob'ev G.I., Zavenyan Z.S., P.V. i dr. Lechenie metastazov kolorektal'noi etiologii (s obzorom sovremennoi literatury). Annaly khir gepatol 2004; 9: 95-102.
Vorob'ev G.I., P.V., Odaryuk T.S. Tekhnika vypolneniya i neposredstvennye rezul'taty aortopodvzdoshno-tazovoi limfadenektomii (s lateral'noi limfodissektsiei) pri rake nizhneampulyarnogo otdela pryamoi kishki. Annaly khirurgii 2000; 1: 52-57.
Skipenko O.G., Zavenyan Z.S., Bagmet N.N. i dr. Rezektsiya pecheni: blizhaishie rezul'taty 132 operatsii. Annaly khir gepatol 2006; 11: 23-27.
P.V., Bashankaev B.N., Kravchenko A.Yu. i dr. Otsenka bezopasnosti i effektivnosti D3-limfodissektsii v lechenii opukholei pravoi poloviny tolstoi kishki. Kreativnaya khirurgiya i onkologiya 2010; 4: 15-18.
P.V., Kravchenko A.Yu., Tulina I.A. i dr. Skeletizatsiya nizhnei bryzheechnoi arterii s paraaortal'noi limfadenektomiei v lechenii raka levoi poloviny obodochnoi kishki. Ros zhurn gastroenterol, gepatol i koloproktol 2012; 2: 60-70.
Adam R., Avisar E., Ariche A. et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 2001; 8: 347-353.
Aslam M.I., Kelkar A., Sharpe D. et al. Ten years experience of managing the primary tumours in patients with stage IV colorectal cancers. Int J Surg 2010; 8: 305-313.
Bajwa A., Blunt N., Vyas S. et al. Primary tumour resection and survival in the palliative management of metastatic colorectal cancer. Eur J Surg Oncol 2009; 35: 164-167.
Beham A., Rentsch M., Pullmann K. et al. Survival benefit in patients after palliative resection vs non-resection colon cancer surgery. World J Gastroenterol 2006; 12: 6634-6638.
Benoist S., Pautrat K., Mitry E. et al. Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Surg 2005; 92: 1155-1160.
Costi R., Mazzeo A., Di Mauro D. et al. Palliative resection of colorectal cancer: does it prolong survival? Ann Surg Oncol 2007; 14: 2567-2576.
Evans M.D., Escofet X., Karandikar S.S. et al. Outcomes of resection and non-resection strategies in management of patients with advanced colorectal cancer. World J Surg Oncol 2009; 7: 28.
Frago R., Kreisler E., Biondo S. et al. Outcomes in the management of obstructive unresectable stage IV colorectal cancer. Eur J Surg Oncol 2010; 36: 1187-1194.
Galizia G., Lieto E., Orditura M. et al. First-line chemotherapy vs bowel tumor resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastases. Arch Surg 2008; 143: 352-358.
Kaufman M.S., Radhakrishnan N., Roy R. et al. Influence of palliative surgical resection on overall survival in patients with advanced colorectal cancer: a retrospective single institutional study. Colorectal Dis 2008; 10: 498-502.
Konyalian V.R., Rosing D.K., Haukoos J.S. et al. The role of primary tumour resection in patients with stage IV colorectal cancer. Colorectal Dis 2007; 9: 430-437.
Law W.L., Chan W.F., Lee Y.M. et al. Non-curative surgery for colorectal cancer: critical appraisal of outcomes. Int J Colorectal Dis 2004; 19: 197-202.
Liu S.K., Church J.M., Lavery I.C. et al. Operation in patients with incurable colon cancer - is it worthwhile? Dis Colon Rectum 1997; 40: 11-14.
Makela J., Haukipuro K., Laitinen S. et al. Palliative operations for colorectal cancer. Dis Colon Rectum 1990; 33: 846-850.
Michel P., Roque I., Di Fiore F. et al. Colorectal cancer with non-resectable synchronous metastases: should the primary tumor be resected? Gastroenterol Clin Biol 2004; 28: 434-437.
Mik M., Dziki L., Galbfach P. et al. Resection of the primary tumour or other palliative procedures in incurable stage IV colorectal cancer patients? Colorectal Dis 2010; 12: 61-67.
Platell C., Ng S., O'Bichere A. et al. Changing management and survival in patients with stage IV colorectal cancer. Dis Colon Rectum 54: 214-219.
Ruo L., Gougoutas C., Paty P.B. et al. Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg 2003; 196: 722-728.
Scheer M.G., Sloots C.E., van der Wilt G.J. et al. Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases. Ann Oncol 2008; 19: 1829-1835.
Scoggins C.R., Meszoely I.M., Blanke C.D. et al. Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol 1999; 6: 651-657.
Seo G.J., Park J.W., Yoo S.B. et al. Intestinal complications after palliative treatment for asymptomatic patients with unresectable stage IV colorectal cancer. J Surg Oncol 102: 94-99.
Stelzner S., Hellmich G., Koch R. et al. Factors predicting survival in stage IV colorectal carcinoma patients after palliative treatment: a multivariate analysis. J Surg Oncol 2005; 89: 211-217.
Tebbutt N.C., Norman A.R., Cunningham D. et al. Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases. Gut 2003; 52: 568-573.
Tol J., Koopman M., Cats A. et al. Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer. N Engl J Med 2009; 360: 563-572.
Venderbosch S., de Wilt J.H., Teerenstra S. et al. Prognostic value of resection of primary tumor in patients with stage IV colorectal cancer: retrospective analysis of two randomized studies and a review of the literature. Ann Surg Oncol 2011; 18: 3252-3260.
Yun H.R., Lee W.Y., Lee W.S. et al. The prognostic factors of stage IV colorectal cancer and assessment of proper treatment according to the patient's status. Int J Colorectal Dis 2007; 22: 1301-1310.

Close metadata